Mehdi ZOGHİ

Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Anabilim Dalı

Research areas: Health Sciences, Medicine, Internal Medicine Sciences, Cardiovascular, Surgery Medicine Sciences, Pharmacology and Therapeutics, Cardiovascular System Surgery, Basic Pharmaceutics Sciences, Fundamental Medical Sciences, Medical Ecology and Hydroclimatology

Publications

• Efficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study (2026)
• Low‐Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real‐World Study (2026)
• Association between PRECISE-DAPT score and clinical outcomes: a subgroup analysis of the DAPT-TR registry (2026)
• Cardiologists’ Diagnostic and Therapeutic Approaches in the Outpatient Management of Patients with Chronic Coronary Syndrome in Turkey: An Observational–Registration Study (2026)
• Epidemiology, comorbidity profiles, and oral anticoagulation patterns among patients with atrial fibrillation in Turkey: a meta-analysis of national registry-based and multicenter observational studies (2026)
• Blood Pressure and Angina-Related Health Status During Benidipine Therapy: A Multicenter Real-World Cohort Study (2026)
• 300.09 Clinical Outcomes in Patients With Ischemic Versus Non-Ischemic Cardiomyopathy After Angiotensin-Neprilysin Inhibition Therapy (2025)
• Artificial Intelligence and Coronary Artery Calcium Scoring: Enhancing Cardiovascular Risk Assessment (2025)
• Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure (2025)
• On Neurocardiology Updates: an Interdisciplinary Field at the Intersection of Neurology and Cardiology (2025)
• Coenzyme Q10 in Contrast-induced Nephropathy - A Step Forward in Renal Protection? (2025)
• Diferenças entre Duas Condições Cardíacas Hipertróficas Distintas: Doença de Fabry Versus Cardiomiopatia Hipertrófica (2024)
• Técnica de modificación externa del calcio para superar una oclusión total crónica no superable con balón (2024)
• Physicians’ attitudes toward beta‐blockers for the treatment of hypertension in Italy, Poland, and Turkey (2024)
• Terapia Antiplaquetária Dupla Combinada em Pacientes com Doença Arterial Coronariana em uma População na Turquia: DAPT-TR (2024)
• Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR (2024)
• Effects of cardiac rehabilitation on functional capacity, psychological symptoms and quality of life in patients with left ventricular assist device (2024)
• Renal Dysfunction Determinants in Advanced Heart Failure Patients: Pulmonary Artery Catheterization Study (2023)
• Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis) (2023)
• Awareness and Knowledge of Pneumococcal Vaccination in Cardiology Outpatient Clinics and the Impact of Physicians’ Recommendations on Vaccination Rates (2023)
• Earthquakes and Cardiovascular Diseases (2023)
• Obstructive – Nonobstructive hypertrophic cardiomyopathy: differences and predictors (2023)
• Premature Atrial Contraction-Induced Cardiomyopathy: Recognition of a Distinct Phenotype of Arrhythmia-Induced Cardiomyopathy in Humans (2023)
• The outcome of peripartum cardiomyopathy patients‐single center experience (2022)
• Characteristics and long‐term survival of patients with left ventricular non‐compaction cardiomyopathy (2022)
• Evaluation of Demographic, Clinical, and Etiological Data of Patients Admitted to Cardiology Clinics And Diagnosed with Left Ventricular Hypertrophy (LVH) on Electrocardiography And/Or Echocardiography: LVH-TR (2022)
• The outcome of peripartum cardiomyopathy patients‐single center experience (2022)
• Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches (2022)
• Agonist-lnduced in Vitro Platelet Aggregation in Type 2 Diabetic and Non-diabetic Coronary Artery Patients (2022)
• Opinions of cardiologists on class II recommendations in current European Society of Cardiology 2018-2020 guidelines: YELLOW BOX (2022)
• Endocarditis-TR: Diagnosis, treatment, and prognosis of the infective endocarditispatients admitting tertiary centres of Turkey (2022)
• Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR) (2022)
• Endocarditis-TR: diagnosis, treatment and prognosis of the infective endocarditis patients admitting tertiary centers of Turkey (2022)
• The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study) (2022)
• Awareness and knowledge of pneumococcal vaccination in cardiology outpatient clinics and impact of physicians' recommendation on vaccination rates (2022)
• The Correlation Between Education Levels and Lifestyles of Patients Admitted Cardiology Clinics: A Subgroup Analysis of Medlife-TR Study (2022)
• Understanding the Burden of Atrial Fibrillation and Importance of Screening: A Global Perspective and Recommendations for Turkey (2022)
• Relationship between functional capacity and socioeconomic status in a cohort of Turkish heart failure patients (2022)
• Evaluation of demographic and clinical characteristics of female patients presenting with MINOCA and differences between male patients: A subgroup analysis of MINOCA-TR registry (2022)
• Girişimsel Kardiyoloji Atlası (2021)
• Usefulness of novel Martin/Hopkins and Sampson equations over Friedewald equation in cardiology outpatients: A CVSCORE‐TR substudy (2021)
• The 1-Year impact of coronavirus disease-19 pandemic on clinical research and publications (2021)
• Demographic, clinical characteristics and medications of rehospitalized patients for acute coronary syndrome: boomerang study (2021)
• ENDOCARDITIS-TR: Diagnosis, Treatment and Prognosis of the Infective Endocarditis Patients Admitting Tertiary Centers of Turkey (2021)
• Medications and lifestyles of patients with cardiovascular risk factors and/or disease in turkish patients (medlife-tr) (2021)
• Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR) (2021)
• Noncompliance with Dietary Salt Restriction and Outcomes in Chronic Heart Failure: A Propensity Score Matching Analysis from TREAT-HF Registry (2021)
• Marital status and outcomes in chronic heart failure: Does it make a difference of being married, widow or widower? (2021)
• An assessment of the anxiety, depression, and sleep disorders experienced by cardiologists during the COVID-19 pandemic (2021)
• One‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study (2021)
• Assessment of Anxiety, Depression and Sleep Disorder Among Cardiology Physicians During COVID-19 Pandemic (2020)
• Demographic, Clinical, and Angiographic Characteristics of Atrial Fibrillation Patients Suffering from De Novo Acute Myocardial Infarction (2020)
• Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR (2020)
• Are there any subclinical myocardial dysfunctions in subjects with aortic valve sclerosis? A 3D-speckle tracking echocardiography study (2020)
• Clinical characteristics and in-hospital outcomes of acute decompensated heart failure patients with and without atrial fibrillation (2020)
• Cardiovascular risk unawareness is common in individuals admitting to cardiology outpatient clinics in Turkey: the CVSCORE-TR study (2020)
• HOW MANY MEDICAL SCHOOL STUDENTS WANT TO BE CARDIOLOGIST IN TURKEY? (2020)
• The Effects of an Exercise Empowerment Programme for Older Patients with Heart Failure: A Randomized Controlled Tria (2020)
• Epidemiology and clinical characteristics of hospitalized elderly patients for heart failure with reduced, mid-range and preserved ejection fraction (2020)
• A New Risk Score to Predict In-Hospital Mortality in Elderly Patients With Acute Heart Failure: On Behalf of the Journey HF-TR Study Investigators (2020)
• The Clinical Characteristics of Acute Heart Failure Patients with Mid-Range Ejection Fraction in Turkey: A Subgroup Analysis from Journey HF-TR Study (2020)
• The clinical characteristics of acute heart failure patients with mid-range ejection fraction in Turkey: A subgroup analysis from journey HF-TR study (2020)
• PATIENTS IN TURKEY FROM RAMSES, NOAC-TR, WARFARIN-TR, AFTER DATABASES COMPLY WITH PHASE 3 NOAC TRIALS?(PANAROMIC-AF/TR) (2019)
• In Reply to Keskin and Orhan (2019)
• Timing of Coronary Angiography After Successful Fibrinolytic Therapy in ST-Segment Elevated Myocardial Infarction (2019)
• THE COMPARISON OF THE REAL LIFE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN TURKEY VERSUS THE STUDYPOPULATION OF PHASE 3 NOVEL ORAL ANTICOAGULANT TRIALS: AN ANALYSIS OF NOAC-TR STUDY DATABASE (2019)
• Medications and Lifestyles of Patients with Cardiovascular Risk Factors and/or Diseases in TuRkish Population MedLife-TR (2019)
• [Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR]. (2019)
• Demographic and clinical characteristics of atrial fibrillation patients suffering from an ACS without prior revascularization history (2019)
• EARLY CLINICAL EXPERIENCE IN TURKEY OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI) IN PATIENTS HEART FAILURE WITH REDUCED EJECTION FRACTION: AN OBSERVATIONAL STUDY (2019)
• KNOWN BUT UNPROVEN FACTS: THE NUTRITIONAL AND IMMUNE SYSTEM’S STATUS AFFECT THE INFECTIVE ENDOCARDITIS HOSPITAL MORTALITY (OA-18) (2019)
• Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey (2019)
• Cardiac autonomic dysfunctions are recovered with vitamin D replacement in apparently healthy individuals with vitamin D deficiency (2019)
• Rationale and design of the Myocardial Infarction with Non-obstructive Coronary Arteries in Turkish Population (MINOCA-TR) study. (2019)
• Prevalence and clinical profile of patients with myocardial infarction with non-obstructive coronary arteries in Turkey (MINOCA-TR): A national multi-center, observational study (2019)
• Differences in atrial fibrillation management strategies among physicians: A survey based study (2019)
• The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. (2019)
• 2017/788 Esas No’lu idari dava dosyası (2018)
• Endokardit Şüphesiyle Türkiye’de Tersiyer Merkezlere Başvuran Hastaların Tanı, Tedavi ve Prognozları: Endokarditis-TR Çalışmasının İlk Sonuçları (2018)
• The predictors of long-term hospitalization in Turkish heart failure population: A subgroup analysis of journey heart failure-TR study: On behalf of journey heart failure-TR investigators (2018)
• Atrial fibrillation and heart failure: double trouble for hospitalized patients with acute decompensated heart failure (2018)
• Atrial fibrillation and heart failure: double trouble for hospitalized patientswith acute decompensated heart failure (2018)
• ENDOKARDIT ŞÜPHESIYLE TÜRKIYE’DE TERSIYER MERKEZLERE BAŞVURAN HASTALARIN TANI, TEDAVI VE PROGNOZLARI: ENDOCARDITIS-TR ÇALIŞMASININ ILK SONUÇLARI (2018)
• Predictive Value of Cha2ds2-vasc and Cha2ds2-vasc-hs Scores for Failed Reperfusion after Thrombolytic Therapy in Patients with St-elevation Myocardial Infarction (2018)
• ENDOKARDİT ŞÜPHESİYLE TÜRKİYE’DE TERSİYER MERKEZLERE BAŞVURAN HASTALARIN TANI, TEDAVİ VE PROGNOZLARI: ENDOCARDITIS-TR ÇALIŞMASININ İLK SONUÇLARI (SS-73) (2018)
• The relationship between initial systolic blood pressure and in hospital mortality, among hospitalized heart failure patients: on behalf of Journey HF-TR. (2018)
• The prevalence of cardiovascular diseases, risk factors and cardiovascular drug therapy in Turkish very elderly patients admitted to the Cardiology clinics: a subgroup analysis of Elder-Turk study. (2018)
• Türk Diyabetik Akut Kalp Yetersizliği Hasta Popülasyonu (2018)
• TÜRKIYE’DE STEMI TANISIYLA FIBRINOLITIK TEDAVI ALAN VEYA PRIMER PERKUTAN GIRIŞIM YAPILAN HASTALARIN DEMOGRAFIK VE KLINIK ÖZELLIKLERININ KARŞILAŞTIRILMASI: MINOCA-TR ÇALIŞMASI ALT GRUP ANALIZI (2018)
• Kardiyoloji kliniklerine başvuran çok ileri yaş Türk hastalarının kardiyovasküler hastalık prevelansı, risk faktörleri ve kardiyovasküler ilaç kullanımları: ELDER-TURK çalışmasının bir altgrup analizi (2018)
• The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study (2018)
• Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study (2018)
• The real-life data of hospitalized patients with heart failure: On behalf of the Journey HF-TR study investigators (2018)
• The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study (2018)
• The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. (2018)
• Atrial fibrillation and heart failure: double trouble for hospitalized patients with acute decompensated heart failure (2018)
• Hastane Öncesi Acil Bakımda Temel ve İleri Yaşam Desteği (2017)
• Kalp Yetersizliği Olan Yaşlı Bireylerde Egzersiz Programının Sonuçları: Güçlendirme Modeli (2017)
• HeartWare Continous Flow left ventricular assist device early mortality predictors: Single center experience (2017)
• KARDİYAK BELİRTEÇLER (2017)

CV